key: cord-0837607-q6bdsynm
authors: Vurture, Gregory; Palmieri, Alicia; Jacobson, Nina
title: Ovarian Vein Thrombosis after Pelvic Surgery in Patient with Recent Coronavirus Disease 2019
date: 2021-08-08
journal: J Minim Invasive Gynecol
DOI: 10.1016/j.jmig.2021.08.002
sha: 027fa1e6f7666ac0568384c0b2a2af8b63cb7c00
doc_id: 837607
cord_uid: q6bdsynm

An abundance of literature has demonstrated that Coronavirus Disease 2019 (COVID-19) contributes to a hypercoagulable state that is associated with venous thromboembolic events. Data on post-operative complications following mild COVID-19 infection is limited. We report a case of ovarian vein thrombosis (OVT) following pelvic surgery in a patient with a recent mild COVID-19 infection. The patient presented with complaints of fever and worsening right-sided abdominal pain postoperatively and was found to have a right OVT. Thrombophilia workup was negative. The hypercoagulable state of patients diagnosed with COVID-19 may have implications on postoperative complications after gynecologic surgery even in cases of mild infection. Further research is needed to determine the optimal thromboembolic prophylaxis for patients undergoing pelvic surgery after COVID-19 infection.

An abundance of literature has demonstrated that Coronavirus Disease 2019 contributes to a hypercoagulable state that is associated with venous thromboembolic events. Data on post-operative complications following mild COVID-19 infection is limited. We report a case of ovarian vein thrombosis (OVT) following pelvic surgery in a patient with a recent mild COVID-19 infection. The patient presented with complaints of fever and worsening right-sided abdominal pain postoperatively and was found to have a right OVT. Thrombophilia workup was negative. The hypercoagulable state of patients diagnosed with COVID-19 may have implications on postoperative complications after gynecologic surgery even in cases of mild infection. Further research is needed to determine the optimal thromboembolic prophylaxis for patients undergoing pelvic surgery after COVID-19 infection.

Septic Pelvic Thrombophlebitis, Hysterectomy, Robotic Surgery, Hypercoaguability Coronavirus Disease 2019 (COVID-19) has been associated with increased rates of venous thromboembolic events (VTE); up to 27% in patients with severe COVID-19

infections [1] [2] . This risk has been well established in patients with severe COVID-19, but there is limited data on the risk of VTE following mild COVID-19 infection. Studies have found a higher rate of morbidity and mortality, and a higher rate of VTE in patients undergoing surgery with a recent diagnosis of COVID-19 [3] . We present a unique case in which a patient with a recent mild COVID-19 infection developed Ovarian Vein Thrombosis (OVT) after a robotic assisted laparoscopic hysterectomy.

A 46-year-old para 2 presented to the emergency department on post-operative day six with complaints of abdominal pain, fevers, chills, and emesis. The patient underwent an uncomplicated robotic-assisted total laparoscopic hysterectomy, uterosacral ligament fixation, and tension-free vaginal tape sling for pelvic organ prolapse, symptomatic fibroid uterus, and stress urinary incontinence. The patient had a history of COVID-19 infection, diagnosed six weeks pre-operatively, that did not require hospitalization. The hospital policy dictated that a positive COVID-19 result within 90 days does not warrant repeat testing. Therefore, pre-operative COVID-19 testing was not performed. Patient's medical history included asthma and gastroesophageal reflux disease without any prior surgical history. Patient's body mass index was 26. Physical exam revealed a temperature of 99.5 F, normal sinus rhythm (heart rate 91 beats per minute) and oxygen saturation of 97% on room air. Moderate right lower quadrant tenderness was noted with deep palpation. Labs were significant for leukocytosis (white blood cell count of 12,600 mm 3 with 84% neutrophils). A complete metabolic panel was within normal limits. Computed tomography of the abdomen and pelvis demonstrated thrombosis of the right ovarian vein (Figure 1 ). The diagnosis of OVT was made and the patient was started on intravenous gentamicin and clindamycin and therapeutic enoxaparin (1mg/kg). During her hospital stay her abdominal pain improved significantly, she remained afebrile, and leukocytosis resolved. She was discharged on hospital day four on oral amoxicillin/clavulanic acid for 7 days, and oral apixaban to be continued for 6 weeks. Thrombophilia workup including Factor V Leiden R506Q mutation, anticardiolipin antibodies, beta-2 glycoprotein antibodies, and lupus anticoagulant were negative.

Septic pelvic thrombophlebitis (SPT) is a subset of VTE that is often described as a rare complication of the postpartum period. It more rarely occurs in nonpregnant women; however, it can be associated with pelvic surgery, pelvic infections, leiomyomas, and underlying malignancy [4] . SPT can be further classified by two subset diagnoses: ovarian vein thrombosis (OVT) and deep septic pelvic thrombophlebitis (DSPT). OVT typically presents within one week postpartum or postoperatively with abdominal pain, localized to the affected side, fever, and nausea [5] . Approximately 70 to 90% of OVT cases involve the right ovarian vein [5] . The incidence of OVT after vaginal or cesarean delivery has been estimated to be 1 out of 3000 deliveries [4] . The incidence of OVT after gynecological surgery is unknown. Regarding minimally invasive surgery, there is only one case report of SPT after laparoscopic hysterectomy [6] .

The hypercoagulable state present with COVID-19 is known as COVID-19associated coagulopathy (CAC). CAC is associated with an increased rate of venous thromboembolism events (VTE), most notably in critically ill patients hospitalized with COVID-19. CAC is thought to result from endothelial injury, immobilization, and an increase in circulating prothrombotic factors [7] . This is particularly concerning for COVID-19 surgical patients. Studies have shown an increased rate of VTE in patients undergoing surgery in the setting of COVID-19 [3] . Little is known about VTE in patients with a mild COVID-10 infection, however, the rate of VTE in patients after discharge who required an inpatient admission for COVID-19 has been estimated to be 0.48 to 1.6% [8] [9] . In one study looking at 1877 COVID-19 hospital discharges, the diagnosis of VTE was made after 16-51 days with a median of 29 days post-discharge [8] .

Our patient had no risk factors for VTE, beyond a COVID-19 infection diagnosed 6 weeks preoperatively. The risk of VTE after minimally invasive hysterectomy is estimated to be 0.3%. This risk may be increased by a recent COVID-19 infection. In order to assess the need for VTE prophylaxis, a Caprini Risk score was calculated preoperatively. The Caprini score includes 20 variables that are used to stratify a patient's risk of post-operative VTE into low, moderate, and high-risk [10] . According to risk stratification with the Caprini scoring system, our patient was classified as low-risk, and only mechanical VTE prophylaxis was indicated. Nonetheless, we cannot suggest causation based on our understanding of COVID-19 at this present time.

Currently, there are no statistical models for thrombosis risk that account for young, healthy women undergoing minimally invasive surgery following recent COVID-19 infection. This case raises the question as to whether we should lower the threshold for thromboprophylaxis in patients with recent COVID-19 infection, including those with mild symptomatology. Based on this case, we recommend waiting greater than six weeks after a COVID-19 infection to proceed with elective surgery. We would also suggest obtaining a negative COVID-19 test result prior to elective surgery. Ultimately, further research is needed to determine the duration of hypercoagulability following COVID-19 infection and its implications on gynecologic surgery.

Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia

Thromboinflammation and the hypercoagulability of COVID-19

Postoperative mortality among surgical patients with COVID-19: a systematic review and meta-analysis

Ovarian vein thrombosis: incidence of recurrent venous thromboembolism and survival

Duplex Doppler evaluation of puerperal ovarian vein thrombosis

Septic pelvic thrombophlebitis following laparoscopic hysterectomy

Current Overview on Hypercoagulability in COVID-19

Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry

Postdischarge venous thromboembolism following hospital admission with COVID-19

Risk assessment as a guide for the prevention of the many faces of venous thromboembolism

Figure 1 -Abdomen and Pelvis CT depicting the right ovarian vein thrombosis